![Richard Aranda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Aranda
Technik-/Wissenschafts-/F&E-Leiter bei
GOSSAMER BIO, INC.
Vermögen: 107 564 $ am 31.05.2026
Profil
Dr. Richard Aranda, MD, is a Chief Medical Officer at Gossamer Bio, Inc. Dr. Aranda was previously employed as a Vice President-Clinical Development by Receptos LLC, a Vice President-Medical Science & Inflammation by Novo-Nordisk Biochem, Inc., and a Principal by Bristol Myers Squibb Co. He received his undergraduate degree from the University of California, Santa Cruz and a doctorate degree from Stanford School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GOSSAMER BIO, INC. 0,1 % | 19.03.2026 | 465.645 ( 0,1 % ) | 107 564 $ | 31.05.2026 |
Aktive Positionen von Richard Aranda
| Unternehmen | Position | Beginn |
|---|---|---|
| GOSSAMER BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2021 |
Ehemalige bekannte Positionen von Richard Aranda
| Unternehmen | Position | Ende |
|---|---|---|
| RECEPTOS INC | Corporate Officer/Principal | 01.01.2018 |
Novo-Nordisk Biochem, Inc. | Corporate Officer/Principal | 01.01.2015 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.05.2011 |
Ausbildung von Richard Aranda
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
University of California, Santa Cruz
 University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo-Nordisk Biochem, Inc. | |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Stanford School of Medicine
 Stanford School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
